Google Preferred SourcesComments
ForumsShare

'Betrayal': 6 reactions to FDA's approval of generic abortion drug

By Samantha Kamman, Christian Post Reporter

2. Kiki Freedman

A pro-abortion rights activist holds a box of mifepristone during a rally in front of the US Supreme Court on March 26, 2024, in Washington, D.C.
A pro-abortion rights activist holds a box of mifepristone during a rally in front of the US Supreme Court on March 26, 2024, in Washington, D.C. | Drew Angerer/AFP via Getty Images

Kiki Freedman, co-founder and CEO of Hey Jane, an organization that delivers abortion-inducing drugs to women through the mail, celebrated the FDA’s approval of the generic form of mifepristone. 

“By expanding generic options, the agency is reinforcing mifepristone’s impeccable safety record,” Freedman said in a statement to The Guardian. “At a time when politically motivated attacks threaten to undermine science and restrict care, it’s critical to underscore that the science couldn’t be clearer.”

Samantha Kamman is a reporter for The Christian Post. She can be reached at: samantha.kamman@christianpost.com. Follow her on Twitter: @Samantha_Kamman

Was this article helpful?

Become a CP Insider.
Help keep The Christian Post free for everyone.

The truth has a cost, and Insiders help carry it.
A dollar from an Insider comes with no strings attached. It keeps our reporters on the story, keeps our journalism open to everyone, and keeps every editorial decision in the newsroom, where it belongs.

Become a CP Insider and choose the amount you want to pay. You can change, pause or cancel anytime. As a thank-you, you’ll get:

  • The Insider Newsletter, a members-only monthly letter from our newsroom

  • Ad-free reading across christianpost.com


From as low as $8.25/month
Prefer to give once?

We’re sorry to hear that.

Hope you’ll give us another try and check out some other articles.
Return to homepage.

Most Popular

More Articles